-
The World Health Organization (WHO) has reaffirmed its guidance that women living with HIV or at high risk of HIV infection can safely use all hormonal contraceptives without restriction following a recent review of links between the contraceptives and HIV acquisition.
-
Reaching young people with an HIV prevention message is important: The Centers for Disease Control and Prevention (CDC) estimates young people ages 13-29 accounted for 39% of all new HIV infections in 2009.
-
With relatively few contraindications to use, progestin-only pills might be a possible candidate for over-the-counter (OTC) use in the United States. But what will it take to move progestin-only pills to the drugstore shelves?
-
Clinicians and researchers now have more comprehensive parameters to assess the stages of menopause with updated criteria known as the Stages of Reproductive Aging Workshop +10 (STRAW +10).
-
African-American women at risk for HIV are the focus of a new prevention program launched by the Centers for Disease Control and Prevention (CDC). "Take Charge. Take the Test" is running in 10 cities where such women are especially hard-hit by the disease.
-
Another oral contraceptive (OC) packaging alert has been issued. Check your clinic's stock for norgestimate and ethinyl estradiol birth control pills distributed by Glenmark Generics.
-
Public health officials are sounding the alarm on the growing threat of multi-drug resistant gonorrhea. What will it take to turn the tide against gonorrhea, the second most commonly reported communicable disease in the United States?
-
The next patient is a 16-year-old young mother who became pregnant at 14 when the condom broke during intercourse and no emergency contraception was used after the method failure.
-
Results of a paper presented at the recent Annual Clinical Meeting of the American College of Obstetricians and Gynecologists suggest that an investigational low-dose contraceptive patch appears to be as effective as a combined oral contraceptive (COC).1
-
If your practice includes care of pregnant women, be sure they are being tested for chlamydia and gonorrhea. Results of a new national analysis of laboratory tests of 1.3 million pregnant women indicate just 59% and 57% of pregnant women were tested at least once for chlamydia and gonorrhea, respectively.
